Home > Healthcare > Medical Devices > Vitrification Market

Vitrification Market – By Product Type (Devices [Open System, Closed System], Kits, Reagents), Specimen (Embryos, Oocytes, Sperms), End-use (IVF Clinics, Biobanks) – Global Forecast 2024 ­ 2032

  • Report ID: GMI10188
  • Published Date: Jul 2024
  • Report Format: PDF

Vitrification Market Size

Vitrification Market size was valued at USD 7.9 billion in 2023, growing at a CAGR of 10.1% between 2024 and 2032. Vitrification is a rapid freezing technique used in cryopreservation to convert a liquid into a glass-like solid without the formation of ice crystals. This method is particularly valuable in preserving biological specimens such as embryos, oocytes, and stem cells, as it minimizes cellular damage during the freezing and thawing processes.

Vitrification Market

Further, vitrification maintains the integrity and viability of the preserved materials, making it a preferred technique in fields such as reproductive medicine and biotechnology. The market is experiencing dynamic growth driven by increasing demand for advanced cryopreservation techniques in fertility treatments. The WHO estimates that 60 to 80 million couples globally experience infertility. Southern and Eastern Europe, along with East Asia, have some of the lowest fertility rates, averaging 1.5 children per woman. Similarly, it is observed that the use of assisted reproductive technology (ART) has grown by 5% to 10% annually.

This rise in ART has led to increased demand for fertility treatments, thereby boosting the need for in vitro fertilization (IVF) services. Thus, the rising demand for infertility treatments strengthens the need for the vitrification method, thereby driving market growth. Additionally, the growing focus on biobanking and regenerative medicine further fuels market expansion, as vitrification is crucial for the long-term storage of biological specimens.

Vitrification Market Trends

The growing awareness and acceptance of IVF as a solution for infertility has been a key driver in the expansion of the market. As more individual become informed about IVF as a viable option, the demand for effective fertility preservation techniques such as vitrification, has surged. Also, vitrification enhances the success rates of IVF by preserving oocytes and embryos with minimal cellular damage. Thus, the increasing acceptance and adoption of IVF have fuelled the need for advanced cryopreservation methods, thereby propelling the growth of the market.

  • For instance, the first of June marks the beginning of World Infertility Awareness Month, dedicated to raising global awareness about the widespread impact of infertility on individuals of all genders, backgrounds, and lifestyles. This campaign aimed to support extending to management of fertility issues, fostering an inclusive workplace environment. This campaign aimed to increase awareness and consequently drive demand for fertility treatments.

Thus, the rising awareness and the proven benefits of vitrification in improving IVF outcomes have been instrumental in driving the expansion of this market.

Vitrification Market Analysis

Vitrification Market, By Product Type, 2021 – 2032 (USD Billion)

Based on the product type, the market is classified into devices, kits, and reagents & consumables. The devices segment dominated the market with a revenue of USD 3.7 billion in 2023.

  • The vitrification devices such as vitrification warming devices and automated vitrification systems are essential for achieving optimal freezing and thawing conditions without compromising sample viability. Their precision and automation capabilities ensure consistent and reliable outcomes, which are crucial in fields like ART and biobanking. Thus, the demand for advanced cryopreservation techniques has surged the reliance on sophisticated devices, thus driving the device segment's prominence in the market.
  • Additionally, strategic initiatives such as product launches, mergers, and the expansion of advanced systems continue to drive growth in this dynamic segment.


Vitrification Market , By Specimen (2023)

Based on the specimen, the global vitrification market is classified into embryos, oocytes, and sperms. The oocytes segment dominated the market with a market share of 47.9% in 2023.

  • Many major companies are providing devices, kits, and consumables for oocyte vitrification which contribute to the market growth. For instance, in March 2022, Shanghai Horizon Medical Co., Ltd. received medical device registration approval from the Zhejiang Provincial Drug Administration for their independently developed CryoX Vitrification Device (CryoX). CryoX is suitable for vitrifying oocytes and embryos. This approval marked a significant advancement in the company’s product offerings thereby enhancing reproductive health solutions.
  • Furthermore, the sperms segment is projected to witness the fastest CAGR of 10% due to the growing advancements in 3D printing to introduce new approaches for manufacturing freezing devices.

Based on the end-use, the global vitrification market is classified into invitro fertilization clinics, and biobanks. The invitro fertilization clinics segment is expected to reach USD 10.7 billion by end of 2032.

  • IVF clinics extensively use vitrification for preserving oocytes and embryos, ensuring high survival rates and better outcomes for fertility treatments. This method's efficiency in preventing ice crystal formation, which can damage cells, makes it indispensable in IVF procedures. Therefore, the growing demand for fertility treatments, coupled with advancements in vitrification techniques, has solidified the dominance of IVF clinics in the market, thereby driving further adoption and market expansion.


North America Vitrification Market , 2021 – 2032 (USD Billion)

In 2023, the U.S. held the highest market revenue of USD 3.4 billion in the North American vitrification market and is expected to dominate throughout the forecast period.

  • The U.S. prominence was asserted to the high infertility rate in the country along with the widespread adoption of ART technology propelling the market demand.
  • For instance, according to data published by the U.S. Department of Health and Human Services (HHS), infertility affects millions of Americans during their lifetime. In 2021, 86,146 infants (approximately 2.3% of all U.S. births) were born through ART. Thus, IVF allows individuals using fertility preservation services to store eggs, sperm, or reproductive tissues for future conception.
  • Further, the country's supportive regulatory environment, coupled with substantial investments in research and development, continues to fuel innovation and market growth in vitrification technologies. This positions the U.S. as a key driver of advancements and market expansion.

Germany is expected to hold a prominent position in the European vitrification market holding a substantial share in 2023.

  • Germany holds a prominent position in the market due to several key factors. The country's advanced healthcare infrastructure and robust regulatory framework support the widespread adoption of advanced cryopreservation techniques, including vitrification, in fertility treatments and research. Therefore, German regulations ensure high standards of safety, efficacy, and ethical practice in ART, fostering trust among patients and healthcare providers.
  • Moreover, Germany's strong emphasis on research and innovation in biotechnology and medical sciences contributes to continuous advancements in vitrification technologies. These factors collectively reinforce Germany's role as a pivotal player in shaping the future growth and development of the European market.

The Asia Pacific vitrification treatment market is expected to grow with a significant CAGR of 10.6% during the forecast period.

  • The evolving regulatory landscape supporting IVF procedures has further bolstered market demand in the Asia Pacific region. For instance, in India, the Assisted Reproductive Technology (Regulation) Act of 2021 (ART Act) has significantly impacted the vitrification market. By establishing a regulatory framework for ART clinics and banks, the ART Act ensures standardized practices and enhances the quality and safety of fertility treatments. This regulation aimed to boost confidence among patients and healthcare providers, leading to increased adoption of ART procedures, including vitrification. The act's emphasis on ethical practices and patient rights also encourages more individuals to opt for fertility preservation, thereby driving growth in the market in India.
  • Additionally, the increasing presence of companies such as Kitazato, Shenzhen VitaVitro Biotech, Cryologic, and Cryotech Lab, which provide vitrification products further indicated the market expansion.

Vitrification Market Share

The market is characterized by the presence of key players focusing on developing advanced technologies and expanding their market reach. The major key players lead the market with their comprehensive portfolios of vitrification devices, kits, and consumables. These companies compete based on product innovation, regulatory approvals, strategic collaborations, and geographical expansion. Additionally, emerging players are gaining traction by introducing novel solutions and enhancing offerings in the rapidly evolving field of cryopreservation.

Vitrification Market Companies

Prominent players operating in the vitrification market are as mentioned below:

  • Biotech, Inc.
  • CooperSurgical Fertility Company
  • FUJIFILM Irvine Scientific
  • Genea BIOMEDX
  • IMV Technologies Group (Cryo Bio System)
  • Kitazato Corporation.
  • MFC Global 
  • NidaCon International AB
  • Optimas 
  • Shenzhen VitaVitro Biotech
  • Vitrolife 

Vitrification Industry News:

  • In July 2023, Ivy Fertility expanded its partnership with TMRW Life Sciences to automate its IVF lab using TMRW's innovative platform for safe storage of frozen eggs and embryos. Previously available at two clinics, TMRW's technology will now be implemented across all 13 Ivy Fertility clinics in the U.S. This expansion aimed to enhance IVF procedures and drive demand for vitrification techniques in the market.
  • In December 2021, VitaVitro received marketing approval for its Vitrification and Warming Kit in China, essential for cooling and warming oocytes, embryos, and blastocysts. These approvals complete VitaVitro's cryopreservation system authorization in China, marking the official start of sales in the country. This approval aimed to strengthen VitaVitro's sales in China.

The vitrification market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

  • Devices
    • Open system
    • Closed system
  • Kits
  • Reagents & consumables

Market, By Specimen

  • Embryos
  • Oocytes
  • Sperms

Market, By End-use

  • In vitro fertilization clinics
  • Biobanks

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • The Netherlands
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global vitrification market was valued at USD 7.9 billion in 2023 and will grow at 10.1% CAGR during 2024-2032, driven by increasing demand for advanced cryopreservation techniques in fertility treatments.

The vitrification devices market reached a revenue of USD 3.7 billion in 2023 and will expand rapidly by 2032, as their precision and automation capabilities ensure consistent and reliable outcomes, which are crucial in fields like ART and biobanking.

U.S. vitrification market size was USD 3.4 billion in 2023 and will expand through 2032, owing to high infertility rate in the country along with the widespread adoption of ART technology.

Biotech, Inc., CooperSurgical Fertility Company, FERTIPRO NV, FUJIFILM Irvine Scientific, Genea BIOMEDX, IMV Technologies Group (Cryo Bio System), Kitazato Corporation, MFC Global, MINITÜB GMBH, NidaCon International AB, Optimas, Shenzhen VitaVitro Biotech, and Vitrolife among others.

Vitrification Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 242
  • Countries covered: 22
  • Pages: 120
 Download Free Sample